Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Promore Pharma

Mindre end 1K følgere
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse14.1.2025, 16.38

PMD Device Solutions' Bankruptcy Application Granted

Promore Pharma
Selskabsmeddelelse22.12.2024, 15.03

PMD Device Solutions AB (publ) has Filed for Bankruptcy

Promore Pharma
Selskabsmeddelelse29.11.2024, 07.00

Q3 Interim report July - September 2024

Promore Pharma

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse26.11.2024, 07.30

PMD Device Solutions Completes Sale of Coala Life Monitor to Inventor Magnus Sörlander

Promore Pharma
Selskabsmeddelelse20.11.2024, 12.12

PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report

Promore Pharma
Selskabsmeddelelse5.11.2024, 15.37

PMDS announces last day of trading in BTA

Promore Pharma
Selskabsmeddelelse29.10.2024, 13.13

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Selskabsmeddelelse29.10.2024, 13.10

Bulletin from the extraordinary general meeting in PMD Device Solutions AB (publ)

Promore Pharma
Selskabsmeddelelse14.10.2024, 05.00

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Selskabsmeddelelse11.10.2024, 07.22

PMDS’ Largest Shareholder Requests EGM to Appoint New Non-Executive Directors Amid Management Changes

Promore Pharma
Selskabsmeddelelse7.10.2024, 15.01

PMD Device Solutions Restructures to Focus Resources on Global Sales Expansion

Promore Pharma
Selskabsmeddelelse26.9.2024, 11.34

NOTICE OF EXTRAORDINARY GENERAL MEETING IN PMD DEVICE SOLUTIONS AB (PUBL)

Promore Pharma
Pressemeddelelse17.9.2024, 11.39

PMD Device Solutions’ RespiraSense Technology Demonstrates Capability in Predicting 7-Day Mortality

Promore Pharma
Selskabsmeddelelse12.9.2024, 14.55

PMDS carries out a directed issue of shares to underwriter in the completed rights issue

Promore Pharma
Pressemeddelelse11.9.2024, 06.04

PMDS Secures New Contract in the Western United States, Accelerating Path to Profitability

Promore Pharma
Pressemeddelelse5.9.2024, 17.18

PMD Device Solutions Secures Significant Sales Contract, Setting the Stage for Significant Growth in the US

Promore Pharma
Selskabsmeddelelse4.9.2024, 19.44

PMDS announces outcome of rights issue

Promore Pharma
Pressemeddelelse27.8.2024, 08.34

Redeye: PMD Solutions - PMD is approaching a cash-positive run rate before 2025

Promore Pharma
Selskabsmeddelelse22.8.2024, 06.00

Q2 Interim report April-June 2024

Promore Pharma
Selskabsmeddelelse16.8.2024, 21.15

PMDS publishes information memorandum in connection with the forthcoming rights issue

Promore Pharma
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.